NCT00705263View on ClinicalTrials.gov

Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Hepatitis C, ChronicHepacivirus
Interventions
BIOLOGICAL

Peginterferon alfa-2b (SCH 54031)

Peginterferon alfa-2b and ribavirin will be administered according to the products' labeling.

DRUG

Ribavirin (SCH 18908)

Peginterferon alfa-2b and ribavirin will be administered according to the products' labeling.

Sponsors

Lead Sponsor

Schering-Plough
All Listed Sponsors
lead

Schering-Plough

INDUSTRY